Coeptis Therapeutics Holdings, Inc.
Market Cap
$72.81K
P/E Ratio
—
EPS
—
Dividend Yield
0.00%
52-Week Range
$0.01 — $0.01
Volume
353.17K
Avg Volume
50.97K
Beta
—
Get alerted when COEPW hits your target price.
Free — enter your email to get started
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.02
P/S (TTM)
27.97
P/B (TTM)
2.66
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.79%
ROA (TTM)
-0.42%
ROIC
—
Gross Margin
-2.08%
Operating Margin
-9.57%
Net Margin
—
Debt/Equity
0.02
Current Ratio
4.16
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-1.44%
EPS Growth (5Y)
-456.31%
Sales Growth (3Y)
-0.33%
Sales Growth (5Y)
+0.09%
EPS Est (This Year)
$-3.40
EPS Est (Next Year)
$-3.60
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$1.50
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
6.22M
Float
5.19M
Free Float %
83.44%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2020-12-17
Employees
4
CEO
David Mehalick
Index Membership
—
Website
https://coeptispharma.com
Coeptis Therapeutics Holdings, Inc. (COEPW) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $72.81K, COEPW is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare COEPW against other stocks using dozens of fundamental and technical filters.
No, Coeptis Therapeutics Holdings, Inc. (COEPW) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Coeptis Therapeutics Holdings, Inc. (COEPW) has a market capitalization of $72,812, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.